Tiny study tracks blood sugar in real life for type 2 diabetes

NCT ID NCT03436212

Completed Knowledge-focused Sponsor: Air Liquide Santé International Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study followed 24 adults with type 2 diabetes who use insulin pumps. Participants wore a continuous glucose monitor for 14 days at home to track blood sugar levels. The goal was to see how glucose levels relate to insulin doses and meals in everyday conditions. It was purely observational and did not test any new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (CGM) device
What this could lead to: If successful, this could help doctors better understand how blood sugar levels change with insulin and meals in daily life, potentially improving diabetes management.
What could go wrong: This is a small, observational study with only 24 participants. It does not test a new treatment, so it cannot directly lead to a cure or new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

CHU de Caen, Service Endocrinologie, Diabétologie

Caen, 14033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.